Literature DB >> 8436909

Differentiation-stage specific self-peptides bound by major histocompatibility complex class I molecules.

P E Harris1, F Lupu, B Hong, E F Reed, N Suciu-Foca.   

Abstract

We have tested the hypothesis that phenotypic changes of development are accompanied by expression of differentiation-stage specific peptides bound to major histocompatibility complex (MHC) class I molecules. The U937 cell line, when cultured in the presence of phorbol myristate acetate (PMA), undergoes differentiation from monoblasts to macrophage-like cells. The high-performance liquid chromatography profile of peptides eluted from purified human histocompatibility leukocyte antigen class I molecules expressed by U937 treated with PMA differs from that obtained from control, untreated U937 cells. Chemical sequencing of eluted peptides identified a peptide derived from cytomegalovirus in both treated and untreated cells. PMA-treated, but not untreated cells, displayed an additional peptide derived from interleukin 1 beta. Hence, differentiation-induction of U937 is accompanied by the presentation of at least one differentiation-stage specific peptide. Our results indicate that, similar to viral infection, cellular development and transformation is accompanied by the de novo synthesis of proteins which are processed and presented on MHC class I molecules.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436909      PMCID: PMC2190941          DOI: 10.1084/jem.177.3.783

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

Review 1.  A molecular model of MHC class-I-restricted antigen processing.

Authors:  J J Monaco
Journal:  Immunol Today       Date:  1992-05

2.  Tumour cells which develop resistance to cytolysis by tumour necrosis factor have a different glycoform of a 105-kDa glycoprotein and lose the capacity to invade and metastasize.

Authors:  M L Neale; R A Fiera; N Matthews
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

3.  Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus.

Authors:  K Weston; B G Barrell
Journal:  J Mol Biol       Date:  1986-11-20       Impact factor: 5.469

4.  Amplification of T cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome.

Authors:  P E Harris; K Strba-Cechova; P Rubinstein; D Mann; D W King; N Suciu-Foca
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 5.  Antigen recognition by class I-restricted T lymphocytes.

Authors:  A Townsend; H Bodmer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

6.  New differentiation antigens associated with the growth and maturation of B lymphocytes.

Authors:  N Suciu-Foca; J D Cai; C Gutiérrea; E Reed; S Morrison; B Pernis; D W King
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

7.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs.

Authors:  C J March; B Mosley; A Larsen; D P Cerretti; G Braedt; V Price; S Gillis; C S Henney; S R Kronheim; K Grabstein
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

8.  Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937.

Authors:  P E Harris; P Ralph; P Litcofsky; M A Moore
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

9.  Detection of IL-1 alpha and IL-1 beta gene expression by in situ hybridization. Tissue localization of IL-1 mRNA in the normal C57BL/6 mouse.

Authors:  L Takács; E J Kovacs; M R Smith; H A Young; S K Durum
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

10.  Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients.

Authors:  E Reed; M Hardy; A Benvenisty; C Lattes; J Brensilver; R McCabe; K Reemstma; D W King; N Suciu-Foca
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

View more
  3 in total

1.  Major histocompatibility complex class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line.

Authors:  P E Harris; A I Colovai; A Maffei; Z Liu; N S Foca
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

2.  Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukemia by tumor-specific T cells.

Authors:  W Sherman; Z Liu; G Inghirami; E F Reed; P E Harris; N M Suciu-Foca
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

3.  Analysis of naturally processed human histocompatibility leukocyte antigen class I-bound peptides from hepatocellular carcinoma tissues in vivo.

Authors:  H Kobayashi; K Sato; N Miyokawa; S Kimura; M Nakashima; M Katagiri
Journal:  Jpn J Cancer Res       Date:  1995-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.